4
Changes in Ownership
Prelude Therapeutics Inc Filed Acc 0001638599-21-000064
Options or other derivatives
- Director bought 166,666 shares at $60.00 ($9,999,960)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| BAKER BROS. ADVISORS LP Director | 2021-01-11 | Purchase · Non-Voting Common Stock | +12,444 | $60.00 | $746,640 | 509,480 | I |
| BAKER BROS. ADVISORS LP Director | 2021-01-11 | Purchase · Non-Voting Common Stock | +154,222 | $60.00 | $9,253,320 | 5,212,371 | I |
Loading xslF345X03/doc4_6992.xml…